Centene reaffirms 2024 adj. diluted EPS guidance of >$6.70 at Barclays conference

CENTENE CORP

Centene will present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024.
The company expects to reaffirm 2024 adjusted diluted EPS guidance of greater than $6.70.
No other financial guidance or changes were disclosed in the filing.

item 7.01

CENTENE CORP filing history →

Source: SEC EDGAR

accession 0001071739-24-000049

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.